Related Experiment Video
Updated: Mar 6, 2026
08:03
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
20.8K
Red Blood Cells for Glucose-Responsive Insulin Delivery
Chao Wang1,2, Yanqi Ye1,2, Wujin Sun1,2
1Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, 27695, USA.
Advanced Materials (Deerfield Beach, Fla.)
|March 8, 2017
Summary
Researchers developed a novel glucose-responsive insulin delivery system using red blood cell membranes. This smart system mimics pancreatic beta cells, offering fast insulin release during hyperglycemia for improved diabetes management.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Diabetes Research
Background:
- Achieving meticulous blood glucose (BG) control through glucose-responsive insulin delivery is crucial for revolutionizing diabetes care.
- Mimicking the natural function of pancreatic beta-cells remains a significant challenge in developing effective insulin therapies.
Purpose of the Study:
- To develop a novel glucose-responsive insulin delivery system.
- To leverage the interaction between glucose derivative-modified insulin and glucose transporters on red blood cell (RBC) membranes for smart insulin release.
Main Methods:
- Insulin was conjugated with glucosamine to create glucose derivative-modified insulin (Glc-Insulin).
- Glc-Insulin was shown to bind efficiently to RBC membranes via glucosamine conjugation.
- A simplified delivery system utilized injectable polymeric nanocarriers coated with RBC membranes and loaded with Glc-Insulin.
Main Results:
- The binding of Glc-Insulin to RBC membranes was demonstrated to be reversible, particularly in hyperglycemic conditions.
- This reversible binding facilitated a rapid release of insulin.
- The system demonstrated a subsequent drop in blood glucose levels in vivo.
Conclusions:
- This study presents the first demonstration of using RBC membranes for smart insulin delivery.
- The developed system exhibits fast responsiveness to changes in glucose levels.
- This approach holds significant potential for advanced diabetes care and blood glucose management.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
7.8K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
01:05Insulin Secretory Vesicles
7.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.9K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.9K
01:28Insulin: The Receptor and Signaling Pathways
5.4K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.7K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.7K
01:06Oral Hypoglycemic Agents: Glinides
780
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
780